Screening DR + tele-ophthalmology AI: Less expensive than human assessmentByLynda ChartersMay 4th 2020
Determining risk of ocular damage from chronic intravitreal injectionsByLynda ChartersApril 24th 2020
Echoes of history: COVID-19 pandemic stirs memories, tests our mettleByPeter J. McDonnell, MDApril 15th 2020
COVID-19: How neuro-ophthalmology is acclimating in the pandemic eraByAlex Delaney-Gesing April 10th 2020
Coronavirus response: Generations react differently to COVID-19ByPeter J. McDonnell, MDApril 9th 2020
How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmologyByLynda ChartersMarch 30th 2020
COVID-19: How eyecare professionals are taking precautions ByRishi P. Singh, MD, FASRSMarch 23rd 2020
IRIS Registry study: Overall anti-VEGF injection intervals for wet AMD similar at 1, 2 years of treatmentByMathew W. MacCumber, MD, PhDMarch 3rd 2020